Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Anesth Analg ; 55(2): 224-8, 1976.
Article in English | MEDLINE | ID: mdl-176904

ABSTRACT

The interaction between pancuronium, d-tubocurarine, polymyxin B, and neostigmine was studied in the rat diaphragm-phrenic nerve preparation. Polymyxin B (5 mug/ml) did not affect twitch tension alone but decreased the pancuronium ED50 from 0.8 mug/ml to 0.32 mug/ml and the d-tubocurarine ED50 from 0.25 mug/ml to 0.15 mug/ml. Neostigmine (0.2 to 10 mug/ml) antagonized pancuronium or d-tubocurarine-induced depression of twitch tension. In contrast, neostigmine (0.001 to 0.2 mug/ml) augmented polymyxin B depression. Similarly, neostigmine (0.1 mug/ml) augmented combined polymyxin B-pancuronium or polymyxin B-d-tubocurarine depression of twitch tension. The authors conclude that polymyxin B potentiates the neuromuscular blockade from pancuronium or d-tubocurarine and that neostigmine further augments this block.


Subject(s)
Neostigmine/pharmacology , Nerve Block , Pancuronium/pharmacology , Polymyxins/pharmacology , Tubocurarine/pharmacology , Animals , Diaphragm/innervation , Dose-Response Relationship, Drug , Drug Synergism , Male , Muscle Contraction/drug effects , Neostigmine/administration & dosage , Neuromuscular Junction/drug effects , Pancuronium/administration & dosage , Phrenic Nerve/drug effects , Polymyxins/administration & dosage , Rats , Tubocurarine/administration & dosage
2.
Anesthesiology ; 42(4): 377-83, 1975 Apr.
Article in English | MEDLINE | ID: mdl-235227

ABSTRACT

d-Tubocurarine (dTc) was infused intravenously into 35 cats anesthetized with chloralose and urethane at a constant continuous rate to produce and maintain 90 per cent depression of twitch height of the anterior tibial muscle following supramaximal stimulation of the peroneal nerve. The mean infusion rates that produced 90 per cent depression were not significantly altered by respiratory acid-base changes. Metabolic alkalosis decreased (32.5 per cent) and metabolic acidosis increased (27.7 per cent) the required infusion rate of dTc. When pH and Paco2 were maintained at 7.37 and 38 torr, respectively, the addition of a bolus of neostigmine, 10.5 mug/kg, intravenously, to the continuing infusion of dTc produced 50 per cent antagonism of the dTc-depressed twitch. Respiratory alkalosis and metabolic acidosis did not alter the dose of neostigmine needed to produce 50 per cent antagonism. However, during respiratory acidosis (pH 7.13, Paco2 66 torr) and metabolic alkalosis (pH 7.59, Paco2 36 torr) 20.0 and 18.0 mug/kg neostigmine, respectively, were needed to produce 50 per cent antagonism. Still larger doses of neostigmine (75 mug/kg) could not completely antagonize the block unless pH and Paco2 were returned to 7.30-7.50 and 35-45 torr, respectively. It is concluded that respiratory acidosis and metabolic alkalosis limit and oppose antagonism of dTc by neostigmine.


Subject(s)
Acid-Base Equilibrium , Neostigmine/pharmacology , Tubocurarine/antagonists & inhibitors , Acidosis/blood , Acidosis/physiopathology , Acidosis, Respiratory/blood , Acidosis, Respiratory/physiopathology , Alkalosis/blood , Alkalosis/physiopathology , Alkalosis, Respiratory/blood , Alkalosis, Respiratory/physiopathology , Anesthesia, Intravenous , Animals , Blood , Carbon Dioxide/blood , Cats , Dose-Response Relationship, Drug , Hydrogen-Ion Concentration , Muscle Contraction/drug effects , Neostigmine/administration & dosage , Partial Pressure
SELECTION OF CITATIONS
SEARCH DETAIL
...